Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam

Arzneimittel-Forschung/Drug Research

Volumn 46, Issue 2, 1996, Pages 213-217

  Zimmermann, Torsten ^a   Yeates, Rodney A ^a   Laufen, Heinrich ^a   Scharpf, Friedrich ^a   Leitold, Matyas ^a   Wildfeuer, Alexander ^a  

^a PFIZER INC   (United States)

Author keywords

antibiotics; azithromycin, drug interaction; CAS 114 07 8; CAS 59467 70 8; CAS 83905 01 5; erythromycin; midazolam, drug interaction; Zithromax

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; ERYTHROMYCIN; HYPNOTIC AGENT; MIDAZOLAM;

ADULT; ALERTNESS; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PSYCHOMETRY; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SLEEP TIME;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CROSS-OVER STUDIES; DRUG INTERACTIONS; ERYTHROMYCIN; FEMALE; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; SLEEP;

EID: 0029987745     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Periti, P., Mazzei, T., Mini, E. et al., Clin. Pharmacokinet. 23, 106 (1992)
2. Ludden, T. M., Clin. Pharmacokinet. 10, 63 (1985)
3. Norrby, S. R., Eur. J. Clin. Microbiol. Infect. Dis. 10, 805 (1991)
4. Goldstein, F. W., J. Antimicrob. Chemother. 25 (Suppl. A), 25 (1990)
5. Foulds, G., Johnson, R. B., J. Antimicrob. Chemother. 31, 39 (1993)
6. Olkolla, K. T., Aranko, K., Luurila, H. et al., Clin. Pharmacol. Ther. 53, 298 (1993)
7. Zimmermann, T., Laufen, H., Yeates, R. A., 7th Eur. Congress on Clinical Microbiology and Infections Diseases, March 27-30, Vienna, A 777 (1995)
8. Allonen, H., Ziegler, G., Klotz, V., Eur. J. Clin. Pharmacol. Ther. 30, 653 (1981)
9. Schall, R., Hundt, H. K. L., Luus, H. G., Int. J. Clin. Pharmacol. Ther. 32, 633 (1994)
10. Hollander, M., Wolfe, D. A., Non-parametric statistical methods, 2nd ed., p. 138, John Wiley and Sons, Chichester (1973)
11. Smith, M. T., Eadie, M. J., O'Rourke, B. T., Eur. J. Clin. Pharmacol. 19, 271 (1981)
12. Bornemann, L. D., Min, B. H., Crews, T. et al., Eur. J. Clin. Pharmacol. 29, 91 (1985)
13. Langlois, S., Kreeft, J. H., Chouinard, G. et al., Br. J. Clin. Pharmacol. 23, 273 (1987)
14. Gascon, M.-P., Drayer, P., Eur. J. Clin. Pharmacol. 41, 573 (1991)
15. Watkins, P. B., Pharmacogenetics 4, 171 (1994)
16. Watkins, P. B., Gastroenterol. Clin. (N.A.) 21, 511 (1992)
17. Lalak, N. J., Morris, D. L., Clin. Pharmacokinet. 25, 370 (1993)
18. Harris, S., Morse, I., Hiligoss, D. et al., 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 17-20 October, A597 (1993)
19. Peters, D. H., Friedel, H. A., Mc Tavish, D., Drugs 44, 750 (1992)
20. Backman, J. T., Olkkola, K. T., Neuronen, P. J., Int. J. Clin. Pharmacol. Ther. 33, 356 (1995)
21. Crevoisier, C., Ziegler, W. H., Eckert, M., Brit. J. Clin. Pharmacol. 16, 515 (1983)
22. Hommer, D. W., Matsuo, V., Wolkowitz, O. et al., Arch. Gen. Psychiatry 43, 542 (1986)
23. Perrson, M. P., Nisson, A., Hartwig, P., Clin. Pharmacol. Ther. 43, 324 (1988)
24. Tucker, G. T., Int. J. Clin. Pharmacol. Ther. Toxicol. 30, 550 (1992)
25. Yonkers, K. A., Kando, J. C., Cole, J. O. et al., Am. J. Psychiatry 149, 587 (1992)